1. Home
  2. OTEX vs PCVX Comparison

OTEX vs PCVX Comparison

Compare OTEX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Open Text Corporation

OTEX

Open Text Corporation

HOLD

Current Price

$23.07

Market Cap

5.9B

Sector

Technology

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$59.23

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OTEX
PCVX
Founded
1991
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
7.0B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
OTEX
PCVX
Price
$23.07
$59.23
Analyst Decision
Hold
Strong Buy
Analyst Count
10
4
Target Price
$36.10
$88.25
AVG Volume (30 Days)
1.2M
927.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
4.92%
N/A
EPS Growth
56.36
N/A
EPS
2.58
N/A
Revenue
$2,815,241,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$1.04
N/A
P/E Ratio
$8.78
N/A
Revenue Growth
22.88
N/A
52 Week Low
$19.78
$30.81
52 Week High
$39.90
$65.00

Technical Indicators

Market Signals
Indicator
OTEX
PCVX
Relative Strength Index (RSI) 37.87 47.74
Support Level $21.61 $58.51
Resistance Level $23.71 $63.39
Average True Range (ATR) 0.66 2.10
MACD -0.27 -0.39
Stochastic Oscillator 4.63 10.69

Price Performance

Historical Comparison
OTEX
PCVX

About OTEX Open Text Corporation

Open Text Corp provides data management for enterprise AI, offering a secure data foundation and trusted context for credible AI outcomes across private, public, and sovereign cloud, managed cloud services, API, and on-premises environments. The Company also provides cybersecurity solutions to protect sensitive data, applications and systems across complex hybrid environments, including identity and access management, threat detection and response, data protection and application security. It serves private, public, and regulated sectors, including retail, financial services, government, manufacturing, healthcare, energy, and logistics, with clients. Geographically, it derives maximum revenue from the Americas.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: